Background The axillary lymph node status is critical for breast cancer staging and individualized treatment planning. Purpose To assess the effect of determining axillary lymph node (ALN) metastasis by breast MRI‐derived radiomic signatures, and compare the discriminating abilities of different MR sequences. Study Type Retrospective. Population In all, 120 breast cancer patients, 59 with ALN metastasis and 61 without metastasis, all confirmed by pathology. Field Strength/Sequence 3 .0T scanner with T1‐weighted imaging, T2‐weighted imaging, diffusion‐weighted imaging, and dynamic contrast‐enhanced (DCE) sequences. Assessment Typical morphological and texture features of the segmented tumor were extracted from four sequences, ie, T1WI, T2WI, DWI, and the second postcontrast phase (CE2) of the dynamic contrast‐enhanced sequences. Additional contrast enhancement kinetic features were extracted from all DCE sequences (one pre‐ and seven postcontrast phases). Linear discriminant analysis classifiers were built and compared when using features from an individual sequence or the combination of the sequences in differentiating the ALN metastasis status. Statistical Tests Mann–Whitney U‐test, Fisher's exact test, least absolute shrinkage selection operator (LASSO) regression, and receiver operating characteristic analysis were performed. Results The accuracy/AUC of the four sequences was 79%/0.87, 77%/0.85, 74%/0.79, and 79%/0.85 for the T1WI, CE2, T2WI, and DWI, respectively. When CE2 was augmented by adding kinetic features, the model achieved the highest performance (accuracy = 0.86 and AUC = 0.91). When all features from the four sequences and the kinetics were combined, it did not lead to a further increase in the performance (P = 0.48). Data Conclusion Breast tumor's radiomic signatures from preoperative breast MRI sequences are associated with the ALN metastasis status, where CE2 phase and the contrast enhancement kinetic features lead to the highest classification effect. Level of Evidence 3 Technical Efficacy Stage 2 J. Magn. Reson. Imaging 2019;50:1125–1132.
Purpose: To investigate two deep learning-based modeling schemes for predicting short-term risk of developing breast cancer using prior normal screening digital mammograms in a case-control setting. Methods: We conducted a retrospective Institutional Review Board-approved study on a case-control cohort of 226 patients (including 113 women diagnosed with breast cancer and 113 controls) who underwent general population breast cancer screening. For each patient, a prior normal (i.e., with negative or benign findings) digital mammogram examination [including mediolateral oblique (MLO) view and craniocaudal (CC) view two images] was collected. Thus, a total of 452 normal images (226 MLO view images and 226 CC view images) of this case-control cohort were analyzed to predict the outcome, i.e., developing breast cancer (cancer cases) or remaining breast cancer-free (controls) within the follow-up period. We implemented an end-to-end deep learning model and a GoogLeNet-LDA model and compared their effects in several experimental settings using two mammographic view images and inputting two different subregions of the images to the models. The proposed models were also compared to logistic regression modeling of mammographic breast density. Area under the receiver operating characteristic curve (AUC) was used as the model performance metric. Results: The highest AUC was 0.73 [95% Confidence Interval (CI): 0.68-0.78; GoogLeNet-LDA model on CC view] when using the whole-breast and was 0.72 (95% CI: 0.67-0.76; GoogLeNet-LDA model on MLO + CC view) when using the dense tissue, respectively, as the model input. The GoogleNet-LDA model significantly (all P < 0.05) outperformed the end-to-end GoogLeNet model in all experiments. CC view was consistently more predictive than MLO view in both deep learning models, regardless of the input subregions. Both models exhibited superior performance than the percent breast density (AUC = 0.54; 95% CI: 0.49-0.59). Conclusions: The proposed deep learning modeling approach can predict short-term breast cancer risk using normal screening mammogram images. Larger studies are needed to further reveal the promise of deep learning in enhancing imaging-based breast cancer risk assessment.
Purpose The purpose of this study was to distinguish axillary lymph node (ALN) status using preoperative breast DCE‐MRI radiomics and compare the effects of two‐dimensional (2D) and three‐dimensional (3D) analysis. Methods A retrospective study including 154 breast cancer patients all confirmed by pathology; 80 with ALN metastasis and 74 without. All MRI scans were achieved at a 3.0 Tesla scanner with 7 post‐contrast MR phases sequentially acquired with a temporal resolution of 60 s. MRI radiomic features were extracted separately from a 2D single slice (i.e., the representative slice) and the 3D tumor volume. Several machine learning classifiers were built and compared using 2D or 3D analysis to distinguish positive vs negative ALN status. We performed independent test and 10‐fold cross validation with multiple repetitions, and used bootstrap test, least absolute shrinkage selection operator, and receiver operating characteristic (ROC) curve analysis as statistical tests. Results The highest area under the ROC curve (AUC) was 0.81 (95% confidence intervals [CI]: 0.80–0.83) and 0.82 (95% CI: 0.81–0.82) for 2D and 3D analysis, respectively; the corresponding accuracy was 79% and 80%. The linear discriminant analysis (LDA) classifier achieved the highest classification performance. None of the AUC differences between 2D and 3D analysis was statistically significant for the several tested machine learning classifiers (all P> 0.05). Conclusions Radiomic features from segmented tumor region in breast MRI were associated with ALN status. The separate radiomic analysis on 3D tumor volume showed a similar effect to the 2D analysis on the single representative slice in the tested machine learning classifiers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.